Controlling chronic low-grade inflammation to improve follicle development and survival.
Study Design
- Type d'étude
- Review
- Population
- None
- Intervention
- Controlling chronic low-grade inflammation to improve follicle development and survival. None
- Comparateur
- None
- Critère de jugement principal
- None
- Direction de l'effet
- Mixed
- Risque de biais
- Unclear
Abstract
Chronic low-grade inflammation is one cause of follicle development disturbance. Chronic inflammation exists in pathological conditions such as premature ovarian failure, physiological aging of the ovaries, and polycystic ovary syndrome. Inflammation of the whole body can affect oocytes via the follicle microenvironment, oxidative stress, and GM-CSF. Many substances without toxic side-effects extracted from natural organisms have gradually gained researchers' attention. Recently, chitosan oligosaccharide, resveratrol, anthocyanin, and melatonin have been found to contribute to an improvement in inflammation. This review discusses the interrelationships between chronic low-grade inflammation and follicle development, the underlying mechanisms, and methods that may improve follicle development by controlling the level of chronic low-grade inflammation.
En bref
This review discusses the interrelationships between chronic low‐grade inflammation and follicle development, the underlying mechanisms, and methods that may improve follicles development by controlling the level of chronic low-grade inflammation.
Used In Evidence Reviews
Similar Papers
International journal of molecular sciences · 2018
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights.
Frontiers in immunology · 2018
Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases.
Journal of ovarian research · 2018
Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
Frontiers in pharmacology · 2020
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease.
Molecules (Basel, Switzerland) · 2019
Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways.
The Journal of nutritional biochemistry · 2021